[go: up one dir, main page]

AU5347996A - Preparation for oral administration - Google Patents

Preparation for oral administration

Info

Publication number
AU5347996A
AU5347996A AU53479/96A AU5347996A AU5347996A AU 5347996 A AU5347996 A AU 5347996A AU 53479/96 A AU53479/96 A AU 53479/96A AU 5347996 A AU5347996 A AU 5347996A AU 5347996 A AU5347996 A AU 5347996A
Authority
AU
Australia
Prior art keywords
preparation
oral administration
oral
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53479/96A
Inventor
Mitsuru Ito
Tooru Maki
Atsuko Misumi
Taku Mizutani
Takashi Yamazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of AU5347996A publication Critical patent/AU5347996A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU53479/96A 1995-04-26 1996-04-23 Preparation for oral administration Abandoned AU5347996A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10198895 1995-04-26
JP7-101988 1995-04-26
PCT/JP1996/001094 WO1996033704A1 (en) 1995-04-26 1996-04-23 Preparation for oral administration

Publications (1)

Publication Number Publication Date
AU5347996A true AU5347996A (en) 1996-11-18

Family

ID=14315227

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53479/96A Abandoned AU5347996A (en) 1995-04-26 1996-04-23 Preparation for oral administration

Country Status (3)

Country Link
JP (1) JP4052603B2 (en)
AU (1) AU5347996A (en)
WO (1) WO1996033704A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11196779A (en) * 1998-01-07 1999-07-27 Nonogawa Shoji Kk Granular composition for food
DE10125883A1 (en) 2001-05-28 2002-12-12 Serumwerk Bernburg Ag Medicines containing an effector of glutathione metabolism together with alpha-lipoic acid in the context of kidney replacement therapy
DE10332486A1 (en) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of acute pain
JP4853818B2 (en) * 2005-08-24 2012-01-11 大正製薬株式会社 Solid formulation containing ibuprofen and ambroxol hydrochloride
JP5134802B2 (en) * 2005-09-29 2013-01-30 第一三共ヘルスケア株式会社 Method for preventing reduction of bromhexine hydrochloride content
KR20120112644A (en) * 2010-01-29 2012-10-11 코와 가부시키가이샤 Loxoprofen-containing pharmaceutical composition
JP5238857B2 (en) * 2010-06-30 2013-07-17 興和株式会社 Loxoprofen-containing pharmaceutical composition
JP7024248B2 (en) * 2016-09-01 2022-02-24 大正製薬株式会社 Solid product

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2501201B2 (en) * 1986-09-02 1996-05-29 大正製薬株式会社 Cold medicine
SE461676B (en) * 1989-02-01 1990-03-12 Svenska Rotor Maskiner Ab SCREW ROTOR COMPRESSOR WITH INLET CHAMBER PROVIDED WITH INTERMEDIATE BODY FOR COLLECTION OF VETERINARY
JPH06239763A (en) * 1993-02-18 1994-08-30 Taisho Pharmaceut Co Ltd Medicine for cold

Also Published As

Publication number Publication date
JP4052603B2 (en) 2008-02-27
WO1996033704A1 (en) 1996-10-31

Similar Documents

Publication Publication Date Title
PL322579A1 (en) 2-methyl-thiene-benzodiazeoin prparation for oral administration
AU2638297A (en) Oral pharmaceutical preparation containing ibandronat
AU7572196A (en) Pharmaceutical formulations
AU9187598A (en) Oral preparation
AU5402296A (en) Pharmaceutical composition for transdermic administration
AU6995396A (en) Pharmaceutical formulation
AU6216296A (en) Pharmaceutical compositions
AU6725496A (en) Peroxidase-activating oral compositions
PL314731A1 (en) S(+)-ibuprofen preparations for oral administration
AUPN411195A0 (en) Medicinal composition
AU4928396A (en) Oral compositions
AU4877896A (en) Preparation
AU6973396A (en) Pharmaceutical formulation
AU7590096A (en) Drug composition
PL314732A1 (en) S(+)-ethodolac preparations for oral administration
AU6904896A (en) Pharmaceutical compounds
AU5838398A (en) Rapamycin formulations for oral administration
AU7420494A (en) Rapamycin formulations for oral administration
AU5155096A (en) Pharmaceutical composition
AU2564399A (en) Isoflavanoid formulations for oral administration
AU4400996A (en) Solid formulations for oral administration of cyclosporine a
PL307469A1 (en) Preparation for oral administration
AU5274096A (en) Pharmaceutical compositions
AU5401796A (en) Solid delivery form for oral use
AU7582696A (en) Pharmaceutical formulation